Alignment Healthcare CEO John Kao Sells $21.4M in ALHC Stock — Five Insiders Unload $31.5M
Alignment Healthcare CEO John Kao sold $21.4M in ALHC across 5 transactions, with $87.5M in career sales. President Maroney added $7.9M. Five total insiders sold $31.5M.
Alignment Healthcare CEO John E. Kao sold $21.4 million in ALHC stock across 5 transactions, bringing his career insider sales to $87.5 million. President Dawn Maroney added $7.89 million, and three other insiders contributed to a total of $31.51 million in insider selling.
Five Insiders, $31.5M
| Insider | Title | Transactions | Value | Shares After | Career Sales |
|---|---|---|---|---|---|
| John E. Kao | Chief Executive Officer | 5 | $21.40M | 2,234,294 | $87.5M |
| Dawn Maroney | President | 4 | $7.89M | 1,385,167 | $34.3M |
| Robert Scavo | Chief Information Officer | 2 | $1.30M | 503,014 | $4.5M |
| Christopher Joyce | Chief Legal & Admin Officer | 3 | $0.68M | 307,699 | $6.3M |
| Hyong Kim | Chief Medical Officer | 2 | $0.24M | 349,639 | $5.0M |
| Total: 5 insiders, 16 transactions | $31.51M | ||||
CEO Kao: $87.5M Career Seller
John Kao founded Alignment Healthcare to transform senior care through a technology-driven model. His $87.5 million in career insider sales from the Medicare Advantage-focused company reflects years of systematic equity monetization. He retains 2.23 million shares — a substantial position — but his career sales are roughly 4x the value of his remaining holdings.
President Maroney: $34.3M Career
Dawn Maroney, who runs the company's day-to-day operations, has sold $34.3M in career ALHC stock. Her $7.89M sale in this round was her largest yet. She retains 1.39 million shares, maintaining meaningful alignment, though her selling pace has accelerated.
Healthcare Tech at a Crossroads
Alignment Healthcare operates a tech-enabled platform serving Medicare Advantage patients. The company is in the middle of scaling its model across new markets while pursuing profitability. For the CEO and President to sell $29.3M combined at current levels suggests they view the current valuation as an appropriate level to take profits — regardless of the growth story.
- CEO sold 68% of total: $21.4M of $31.5M — dominant seller
- 5 insiders selling: CEO, President, CIO, CLO, and CMO
- Combined career: $137.6M from these five executives
- CEO's career at $87.5M: Largest single-person total at the company
For ALHC investors, the concentrated selling from the CEO and President warrants attention. When the two people most responsible for Alignment Healthcare's growth strategy sell a combined $29.3M, it's the clearest available signal about their personal assessment of the risk-reward at current prices.
Breaking News Editor at 13F Insight. First to report on major SEC filings, institutional moves, and regulatory developments.
More from Alex →Add the funds and stocks mentioned here to a free watchlist, or get an email the next time they file — no card required.